About Neomend
Neomend is a company based in Irvine (United States) founded in 1999 was acquired by CR Bard in October 2012. Neomend has raised $38.83 million across 3 funding rounds from investors including Blackstone, CR Bard and Sanderling Ventures. Neomend operates in a competitive market with competitors including Cohera Medical, GATT Technologies BV, Sealonix, OptMed and BORAYER, among others.
- Headquarter Irvine, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neomend Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$38.83 M (USD)
in 3 rounds
-
Latest Funding Round
$33.12 M (USD), Series D
Feb 04, 2010
-
Investors
Blackstone
& 5 more
-
Employee Count
Not available
-
Acquired by
CR Bard
(Oct 23, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Neomend
Neomend has successfully raised a total of $38.83M across 3 strategic funding rounds. The most recent funding activity was a Series D round of $33.12 million completed in February 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Neomend
Neomend has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Blackstone, CR Bard and Sanderling Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biomedical investment financing and active management services.
|
Locked | Locked | Locked | |
|
Investments are made in US life sciences and healthtech firms.
|
Locked | Locked | Locked | |
|
Diversified investment management is provided across multiple asset classes.
|
Locked | Locked | Locked |
Investor details for Neomend
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neomend
Investment portfolio details for Neomend
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Neomend
Detailed financials for Neomend
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neomend Comparisons
Peer comparison for Neomend
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neomend
Neomend operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cohera Medical, GATT Technologies BV, Sealonix, OptMed and BORAYER, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Develops innovative surgical adhesives and sealants for medical use.
|
|
| Locked | Locked | Locked |
Polymer-based adhesive tissue tape is developed for surgical sealants.
|
|
| Locked | Locked | Locked |
Developer of hemostatic sealants for surgeries
|
|
| Locked | Locked | Locked |
Biocompatible polymers and genitourinary therapeutics are developed and commercialized.
|
|
| Locked | Locked | Locked |
Biomaterials for surgery and wound repair are developed.
|
Detailed competitors of Neomend
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neomend
Complete news archive for Neomend
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neomend
Neomend was founded in 1999 and raised its 1st funding round 10 years after it was founded.
Neomend is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Neomend is a funded company, having raised a total of $38.83M across 3 funding rounds to date.
Provider of air leak sealant for thoracic surgery. By using the proprietary Hydrogel technology platform the company has developed advanced wound care products for a variety of applications, including wound healing, prevention of post-surgical adhesions, and site-specific, sustained drug delivery. The lead product is Progel Pleural Air Leak Sealant, for lung surgery.
Neomend's top competitors include OptMed, GATT Technologies BV and Sealonix.
Neomend has 6 investors. Key investors include Blackstone, CR Bard, Sanderling Ventures, Prospect Venture Partners, and Vivo Capital.